annual cash & cash equivalents:
$172.77M+$21.92M(+14.53%)Summary
- As of today (May 29, 2025), AAPG annual cash & cash equivalents is $172.77 million, with the most recent change of +$21.92 million (+14.53%) on December 1, 2024.
- During the last 3 years, AAPG annual cash & cash equivalents has fallen by -$95.02 million (-35.48%).
- AAPG annual cash & cash equivalents is now -35.48% below its all-time high of $267.78 million, reached on December 1, 2021.
Performance
AAPG Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$172.77M+$21.38M(+14.12%)Summary
- As of today (May 29, 2025), AAPG quarterly cash & cash equivalents is $172.77 million, with the most recent change of +$21.38 million (+14.12%) on December 1, 2024.
- Over the past year, AAPG quarterly cash & cash equivalents has increased by +$21.92 million (+14.53%).
- AAPG quarterly cash & cash equivalents is now -35.48% below its all-time high of $267.78 million, reached on December 1, 2021.
Performance
AAPG quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
AAPG Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +14.5% | +14.5% |
| 3 y3 years | -35.5% | -35.5% |
| 5 y5 years | +37.6% | +37.6% |
AAPG Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -35.5% | +14.5% | -35.5% | +14.5% |
| 5 y | 5-year | -35.5% | +37.6% | -35.5% | +184.5% |
| alltime | all time | -35.5% | +7510.5% | -35.5% | +184.5% |
AAPG Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $172.77M(+14.5%) | $172.77M(+14.1%) |
| Jun 2024 | - | $151.39M(+0.4%) |
| Dec 2023 | $150.85M(-29.5%) | $150.85M(-30.8%) |
| Jun 2023 | - | $218.04M(+1.9%) |
| Dec 2022 | $213.88M(-20.1%) | $213.88M(-15.6%) |
| Jun 2022 | - | $253.47M(-5.3%) |
| Dec 2021 | $267.78M | $267.78M(+57.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2021 | - | $170.61M(+9.3%) |
| Dec 2020 | $156.12M(+24.3%) | $156.12M(+157.1%) |
| Jun 2020 | - | $60.73M(-51.6%) |
| Dec 2019 | $125.56M(-9.8%) | $125.56M(+13.6%) |
| Jun 2019 | - | $110.48M(-20.6%) |
| Dec 2018 | $139.13M(+6028.9%) | $139.13M |
| Dec 2017 | $2.27M(-94.6%) | - |
| Dec 2016 | $42.41M | - |
FAQ
- What is Ascentage Pharma Group International annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Ascentage Pharma Group International?
- What is Ascentage Pharma Group International annual cash & cash equivalents year-on-year change?
- What is Ascentage Pharma Group International quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Ascentage Pharma Group International?
- What is Ascentage Pharma Group International quarterly cash & cash equivalents year-on-year change?
What is Ascentage Pharma Group International annual cash & cash equivalents?
The current annual cash & cash equivalents of AAPG is $172.77M
What is the all time high annual cash & cash equivalents for Ascentage Pharma Group International?
Ascentage Pharma Group International all-time high annual cash & cash equivalents is $267.78M
What is Ascentage Pharma Group International annual cash & cash equivalents year-on-year change?
Over the past year, AAPG annual cash & cash equivalents has changed by +$21.92M (+14.53%)
What is Ascentage Pharma Group International quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of AAPG is $172.77M
What is the all time high quarterly cash & cash equivalents for Ascentage Pharma Group International?
Ascentage Pharma Group International all-time high quarterly cash & cash equivalents is $267.78M
What is Ascentage Pharma Group International quarterly cash & cash equivalents year-on-year change?
Over the past year, AAPG quarterly cash & cash equivalents has changed by +$21.92M (+14.53%)